Puhlmann Markus 4
4 · Perspective Therapeutics, Inc. · Filed Dec 14, 2023
Insider Transaction Report
Form 4
Puhlmann Markus
Chief Medical Officer
Transactions
- Award
Stock Options (right to buy)
2023-12-12+1,477,619→ 2,885,688 totalExercise: $0.24Exp: 2033-12-12→ Common Stock (1,477,619 underlying)
Footnotes (1)
- [F1]25% vested as of 12/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 12/12/2024, until fully vested.